A Phase 2, Multicenter, Randomized Study Of Trastuzumab Deruxtecan In Subjects With Her2-Overexpressing Locally Advanced, Unresectable Or Metastatic Colorectal Cancer
- Frentzas, Sophia (Primary Chief Investigator (PCI))
Project: Research
Project: Research